Latest available resultsQuarter ended June 30, 202610-Q · August 6, 2026
Filed with the SECBECTON DICKINSON & CO
BDXHealthcare
Next reportNovember 2, 2026after close · Analyst forecast 4.106 $/share
Revenue
$4.98B
▲ +5.4% vs prior year% YoY
Net income
$377.00M
▼ -34.3% vs prior year% YoY
EPS
1.37$
▼ -31.5% vs prior year% YoY
Net margin
7.6%
▼ -4.6 percentage points vs prior year pp YoY
Revenue▲ +5.4 %
Margins (% of revenue)GrossOperatingNet
Net income▼ -34.3 %
EPS▼ -31.5 %
View financial tableQuarter ended June 30, 2026
| Metric | Value | Context |
|---|---|---|
| Operations | ||
| Revenue | $4.98B | |
| Gross profit | $2.31B | 46.5 % |
| Operating income | $663.00M | 13.3 % |
| Net income | $377.00M | 7.6 % |
| R&D | $258.00M | 5.2 % |
| EPS (diluted) | 1.37 $ | |
| Balance sheet | ||
| Assets | $50.73B | |
| Liabilities | $26.32B | |
| Equity | $24.42B | |
| Cash | $708.00M | |
| Capital | ||
| Shares outstanding | 272.39M | as of 2026-06-30 |
| Public float | — | |